|
|
Volumn 14, Issue 4, 1996, Pages 1045-1047
|
|
Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: Have we made progress?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
BCG VACCINE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTOKINE;
DEXAMETHASONE;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
GEMCITABINE;
GRANISETRON;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IRINOTECAN;
LEVAMISOLE;
NAVELBINE;
ONDANSETRON;
PACLITAXEL;
TOPOTECAN;
UFT;
VINDESINE;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
FEMALE;
HUMAN;
INTRAPLEURAL DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
|
|
EID: 0030003690
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1996.14.4.1045 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|
